A novel navigated doxorubicin delivery formulation to breast cancer therapy

Cheng, S; Lu, Z; Feng, Y; Zhao, X; Zhao, R; Qiu, Z; Jia, C; Chen, L; Yuan, Y; Li, X; Gao, Q; Xu, J; Shu, Z; Duan, Wei; Hou, Y; Nie, G; Xiao, L

File(s) not publicly available

A novel navigated doxorubicin delivery formulation to breast cancer therapy

journal contribution

posted on 2022-06-01, 00:00 authored by S Cheng, Z Lu, Y Feng, X Zhao, R Zhao, Z Qiu, C Jia, L Chen, Y Yuan, X Li, Q Gao, J Xu, Z Shu, Wei DuanWei Duan, Y Hou, G Nie, L Xiao

A novel navigated doxorubicin delivery formulation to breast cancer therapy

History

Journal

Materials Today Advances

Volume

14

Article number

100235

Pagination

1 - 14

Publisher

Elsevier

Location

Amsterdam, The Netherlands

Publisher DOI

https://doi.org/10.1016/j.mtadv.2022.100235

Link to full text

https://doi.org/10.1016/j.mtadv.2022.100235

eISSN

2590-0498

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Usage metrics

Keywords

Science & Technology Technology Materials Science, Multidisciplinary Materials Science Breast cancer Targeted drug delivery Doxorubicin Multidrug resistance DRUG-RESISTANCE DIAGNOSIS AGENTS EZH2

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

File(s) not publicly available

A novel navigated doxorubicin delivery formulation to breast cancer therapy

History

Journal

Volume

Article number

Pagination

Publisher

Location

Publisher DOI

Link to full text

eISSN

Language

Publication classification

Usage metrics

Categories

Keywords

Licence

Exports